Search
Sickle Cell Disease: From Research to Clinical Management
Elevate your expertise and impact patient care by joining the EHA's pilot preceptorship on Sickle Cell Disease, designed for early-career hematology specialists, clinicians, lab technicians, and pathologists.
Read moreNomination Committee
Current committee members
Tony Green, United Kingdom (Chair)
Regular members
Maria Ester Bernardo, Italy
Jan Cools, Belgium
Sabine Eichinger, Austria
Shai Izraeli, Israel
Irene Roberts, United Kingdom
AimThe Nomination Committee (NC) is responsible for ensuring the quality of the EHA Board related to scientific and educational background, and balance…
How to apply for CBTH
TimelinesApplication CBTH 2025
Deadline: September 24, 2024 (15:00 CEST)
Notification
November 2024
How to apply?Download the signature letter template. Fill in the template and get it duly signed for upload into the online application platform.
Practical information
Timelines:Application deadline: September 24, 2024 (15:00 CEST)
Notification of awards: December 2024
When & where do the meetings take place?Workshop 1:
Date: April 22-26, 2025
Venue: Cambridge, UK
CBTH session and EHA Congress:
Date: June 11-15, 2025
Venue: TBC
Workshop 2:
Date:…
Thrombocytopenias and Platelet Function Disorders
The SWG was established at the 2003 EHA Congress, which was held in Lyon, France. The group's original focus was thrombocytopenias, but it subsequently expanded its field of interest with the inclusion of platelet function disorders.
Read moreEuropean Research Initiative on CLL (ERIC)
ERIC is devoted to improving the outcome of patients with Chronic Lymphocytic Leukemia (CLL) and related diseases. The objectives of ERIC are to promote:
Research in all aspects of chronic lymphocytic leukemia and related diseases.
Chronic Myeloid Leukemia
The objective of this SWG is the cure of Chronic Myeloid Leukemia (CML) by cooperative research.
Read moreAging and Hematology
The SWG "Aging and Hematology" has four main goals for the next four years (2019-2023):
To share clinically useful tools in assessing frailty and comorbidities in older adults with hematologic malignancies.